Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Palladino, Ilaria ^a   Salani, Francesca ^a   Ciaramella, Antonio ^a   Rubino, Ivo A ^b   Caltagirone, Carlo ^a,b   Fagioli, Sabrina ^a   Spalletta, Gianfranco ^a   Bossù, Paola ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Inflammation; Interleukin 18; Interleukin 18 Binding Protein; Schizophrenia

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SCHIZOPHRENIA;

EID: 84865183572     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-206     Document Type: Article

References (28)

1. Dinarello CA. Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 2000, 11:483-486.
2. Dinarello CA. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 2006, 83:447S-455S.
3. Alboni S, Cervia D, Sugama S, Conti B. Interleukin 18 in the CNS. J Neuroinflammation 2010, 7:9. 10.1186/1742-2094-7-9, 2830964, 20113500.
4. Bossù P, Salani F, Cacciari C, Picchetto L, Cao M, Bizzoni F, Rasura M, Caltagirone C, Robinson RG, Orzi F, Spalletta G. Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr Neurovasc Res 2009, 6:163-170. 10.2174/156720209788970036, 19534720.
5. Bossù P, Ciaramella A, Salani F, Vanni D, Palladino I, Caltagirone C, Scapigliati G. Interleukin-18, from neuroinflammation to Alzheimer's disease. Curr Pharm Des 2010, 16:4213-4224. 10.2174/138161210794519147, 21184660.
6. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999, 10:127-136. 10.1016/S1074-7613(00)80013-8, 10023777.
7. Sims JE. IL-1 and IL-18 receptors, and their extended family. Curr Opin Immunol 2002, 14:117-122. 10.1016/S0952-7915(01)00306-5, 11790541.
8. Novick D, Schwartsburd B, Pinkus R, Suissa D, Belzer I, Sthoeger Z, Keane WF, Chvatchko Y, Kim SH, Fantuzzi G, Dinarello CA, Rubinstein M. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 2001, 14:334-342. 10.1006/cyto.2001.0914, 11497494.
9. Gangemi S, Basile G, Merendino RA, Minciullo PL, Novick D, Rubinstein M, Dinarello CA, Lo Balbo C, Franceschi C, Basili S, D' Urbano E, Daví G, Nicita-Mauro V, Romano M. Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: another paradox of longevity?. Exp Gerontol 2003, 38:669-672. 10.1016/S0531-5565(03)00061-5, 12814802.
10. Novick D, Elbirt D, Miller G, Dinarello CA, Rubinstein M, Sthoeger ZM. High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun 2010, 34:121-126. 10.1016/j.jaut.2009.08.002, 19699611.
11. Mühl H, Kämpfer H, Bosmann M, Frank S, Radeke H, Pfeilschifter J. Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun 2000, 267:960-963. 10.1006/bbrc.1999.2064, 10673399.
12. Kinney DK, Hintz K, Shearer EM, Barch DH, Riffin C, Whitley K, Butler R. A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction. Med Hypotheses 2010, 74:555-563. 10.1016/j.mehy.2009.09.040, 19836903.
13. Meyer U. Developmental neuroinflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2011, PMID: 22122877.
14. Watanabe Y, Someya T, Nawa H. Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin Neurosci 2010, 64:217-230. 10.1111/j.1440-1819.2010.02094.x, 20602722.
15. Shirts BH, Wood J, Yolken RH, Nimgaonkar VL. Comprehensive Evaluation of Positional Candidates in the IL-18 Pathway Reveals Suggestive Associations With Schizophrenia and Herpes Virus Seropositivity. Am J Med Genet B Neuropsychiatr Genet 2008, 147:343-350.
16. Liu J, Liu J, Zhou Y, Li S, Li Y, Song X, Wang J, Wang L, Ying B. Association between promoter variants of interleukin-18 and schizophrenia in a Han Chinese population. DNA Cell Biol 2011, 30:913-917. 10.1089/dna.2011.1221, 21510800.
17. Tanaka KF, Shintani F, Fujii Y, Yagi G, Asai M. Serum interleukin-18 levels are elevated in schizophrenia. Psychiatry Res 2000, 96:75-80. 10.1016/S0165-1781(00)00196-7, 10980328.
18. Reale M, Patruno A, De Lutiis MA, Pesce M, Felaco M, Di Giannantonio M, Di Nicola M, Grilli A. Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls. BMC Neurosci 2011, 25:12-13.
19. Xiu MH, Chen DC, Wang D, Zhang K, Dong A, Tang W, Zhang F, Liu LJ, Liu JH, Liu HB, Yang FD, Kosten TR, Zhang XY. Elevated interleukin-18 serum levels in chronic schizophrenia: association with psychopathology. J Psychiatr Res 2012, 46:1093-1098. 10.1016/j.jpsychires.2012.04.026, 22647522.
20. Spoletini I, Cherubini A, Banfi G, Rubino IA, Peran P, Caltagirone C, Spalletta G. Hippocampi, thalami, and accumbens microstructural damage in schizophrenia: a volumetry, diffusivity, and neuropsychological study. Schizophr Bull 2011, 37:118-130. 10.1093/schbul/sbp058, 3004185, 19542526.
21. Migliorini P, Anzilotti C, Pratesi F, Quattroni P, Bargagna M, Dinarello CA, Boraschi D. Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus. Eur Cytokine Netw 2010, 21:264-271.
22. Mazodier K, Marin V, Novick D, Farnarier C, Robitail S, Schleinitz N, Veit V, Paul P, Rubinstein M, Dinarello CA, Harlé JR, Kaplanski G. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 2005, 106:3483-3489. 10.1182/blood-2005-05-1980, 1895045, 16020503.
23. Ludwiczek O, Kaser A, Novick D, Dinarello CA, Rubinstein M, Tilg H. Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease. Eur Cytokine Netw 2005, 16:27-33.
24. Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M, Dinarello CA. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000, 97:1190-1195. 10.1073/pnas.97.3.1190, 15564, 10655506.
25. Drexhage RC, Hoogenboezem TA, Cohen D, Versnel MA, Nolen WA, van Beveren NJ, Drexhage HA. An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces. Int J Neuropsychopharmacol 2011, 14:746-755. 10.1017/S1461145710001653, 21255481.
26. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 2011, 70:663-671. 10.1016/j.biopsych.2011.04.013, 21641581.
27. Meyer U. Anti-inflammatory signaling in schizophrenia. Brain Behav Immun 2011, 25:1507-1518. 10.1016/j.bbi.2011.05.014, 21664451.
28. Meyer U, Schwarz MJ, Müller N. Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol Ther 2011, 132:96-110. 10.1016/j.pharmthera.2011.06.003, 21704074.